176 related articles for article (PubMed ID: 23870420)
1. Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study.
Birmingham WC; Agarwal N; Kohlmann W; Aspinwall LG; Wang M; Bishoff J; Dechet C; Kinney AY
BMC Health Serv Res; 2013 Jul; 13():279. PubMed ID: 23870420
[TBL] [Abstract][Full Text] [Related]
2. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):603-6. PubMed ID: 15254451
[TBL] [Abstract][Full Text] [Related]
3. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
Giri VN; Walker A; Gross L; Trabulsi EJ; Lallas CD; Kelly WK; Gomella LG; Fischer C; Loeb S
Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
[TBL] [Abstract][Full Text] [Related]
4. Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening.
Rim SH; Hall IJ; Massetti GM; Thomas CC; Li J; Richardson LC
J Cancer Educ; 2019 Aug; 34(4):666-670. PubMed ID: 29582364
[TBL] [Abstract][Full Text] [Related]
5. Association between features of patient-provider discussions and routine prostate-specific antigen testing.
Liao JM; Ommerborn MJ; Clark CR
PLoS One; 2017; 12(5):e0177687. PubMed ID: 28520820
[TBL] [Abstract][Full Text] [Related]
6. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study.
Kanodra NM; Pope C; Halbert CH; Silvestri GA; Rice LJ; Tanner NT
Ann Am Thorac Soc; 2016 Nov; 13(11):1977-1982. PubMed ID: 27676369
[TBL] [Abstract][Full Text] [Related]
7. Patient and Physician Perceptions of Genetic Testing in Primary Care.
Evenson SA; Hoyme HE; Haugen-Rogers JE; Larson EA; Puumala SE
S D Med; 2016 Nov; 69(11):487-493. PubMed ID: 28810112
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists.
Kim SP; Meropol NJ; Gross CP; Tilburt JC; Konety B; Yu JB; Abouassaly R; Weight CJ; Williams SB; Shah ND
Urol Oncol; 2018 Nov; 36(11):501.e15-501.e21. PubMed ID: 30190177
[TBL] [Abstract][Full Text] [Related]
10. Primary Care Providers' Interest in Using a Genetic Test to Guide Alcohol Use Disorder Treatment.
Williams EC; Young JP; Achtmeyer CE; Hendershot CS
J Subst Abuse Treat; 2016 Nov; 70():14-20. PubMed ID: 27692183
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
12. Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.
Rupert DJ; Squiers LB; Renaud JM; Whitehead NS; Osborn RJ; Furberg RD; Squire CM; Tzeng JP
Patient Educ Couns; 2013 Aug; 92(2):188-96. PubMed ID: 23664232
[TBL] [Abstract][Full Text] [Related]
13. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
Kirkegaard P; Edwards A; Nielsen TLO; Ørntoft TF; Sørensen KD; Borre M; Bro F
BMC Fam Pract; 2018 Feb; 19(1):32. PubMed ID: 29454309
[TBL] [Abstract][Full Text] [Related]
14. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
15. Provider Recommendations in the Face of Scientific Uncertainty: An Analysis of Audio-Recorded Discussions about Vitamin D.
Tarn DM; Paterniti DA; Wenger NS
J Gen Intern Med; 2016 Aug; 31(8):909-17. PubMed ID: 27008650
[TBL] [Abstract][Full Text] [Related]
16. Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.
Mayer M; Selig K; Tüttelmann F; Dinkel A; Gschwend JE; Herkommer K
Fam Cancer; 2019 Apr; 18(2):221-230. PubMed ID: 30229510
[TBL] [Abstract][Full Text] [Related]
17. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
18. Attitudes and Beliefs of Primary Care Providers in New Mexico About Lung Cancer Screening Using Low-Dose Computed Tomography.
Hoffman RM; Sussman AL; Getrich CM; Rhyne RL; Crowell RE; Taylor KL; Reifler EJ; Wescott PH; Murrietta AM; Saeed AI; Mishra SI
Prev Chronic Dis; 2015 Jul; 12():E108. PubMed ID: 26160294
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer screening and informed decision-making: provider and patient perspectives.
Bowen DJ; Hannon PA; Harris JR; Martin DP
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):155-61. PubMed ID: 21243007
[TBL] [Abstract][Full Text] [Related]
20. Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk.
Underhill ML; Pozzar R; Chung D; Sawhney M; Yurgelun M
J Cancer Educ; 2020 Feb; 35(1):194-203. PubMed ID: 31701425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
